We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quality Revamp Brings West-Ward Warning Letter Close Out
Quality Revamp Brings West-Ward Warning Letter Close Out
The FDA has closed out a warning letter issued to West-Ward Pharmaceuticals after the generic drugmaker completed a two-year overhaul of parts of its quality system.